Iran Is Merely a Chess Piece in a Much Bigger Game
Watch Jasmine Crockett's Absurd Speech to Her Supporters After Losing the Texas Senate...
That Oyster Farmer With the Nazi Tattoos Who's Trying to Unseat Susan Collins...
Wait, the Austin Police Officers Who Stopped a Terrorist Are Going Before a...
GOP Senators Detail the Consequences of This Dem-Led DHS Shutdown
I Hate You More Than I Love Them
Trump Is Never Accessible Enough to the Press?
Under Trump's Great Leadership, America Is Doing What Must Be Done in Iran
Competition, Not Consolidation, Is the Cure for Rising Healthcare Costs
Ayatollah Khamenei's Miscalculation
Ultimate Success in Iran Is Not As Elusive As Critics Charge
Fourth-Wave Feminism: Reform or Tsunami?
Medical Devices Shouldn’t Become National Security Risks
Let the Senate Debate the SAVE America Act for As Long As Democrats...
Shooting, Stabbing, and Wrong-Way Trucking
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement